Clinical Trial

HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM)

Name: HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM) — clinical trial record (NCT06913959)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: OBSOCAM

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The aim of the study is to study the genotypic characteristics of HIV-1 non-M circulating in the whole Cameroon and their genetic evolution.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-03-31.

Trial Details

NCT Number	NCT06913959
Lead Sponsor	ANRS, Emerging Infectious Diseases Collaborators: University Hospital, Rouen, Centre Pasteur du Cameroun
Conditions	HIV Infection
Enrollment	220 participants
Start Date	2025-06-30
Primary Completion	2027-07-01 (estimated)
Study Completion	2027-07-01 (estimated)
Updated on ClinicalTrials.gov	2025-04-08